NTx Taps Biopharma Industry Executive Nancy Rurkowski to Join its Board of Directors

RIO RANCHO, N.M.–(BUSINESS WIRE)–NTx, biomanufacturing and bioinformatics company, today announced that biopharma industry veteran Nancy Rurkowski has joined its Board of Directors. Rurkowski brings over 35 years of pharmaceutical and biologics operations experience from Bristol-Myers Squibb. Over the course of her career, she held global leadership roles across strategic sourcing, new product launch, global supply […]

NUBURU Bolsters 3D Printing IP with Additional Blue Laser Technology Patent

CENTENNIAL, Colo.–(BUSINESS WIRE)–NUBURU, the leader in high power blue laser technology, today announced that it has been awarded U.S. Patent No. 10,971,896 by the U.S. Patent Office. This new patent covers spatial, polarization and wavelength combination of blue laser diodes to make a high power, high brightness blue laser diode system, which enables significant gains […]

Excision BioTherapeutics Appoints Seasoned Finance Executive Christine Silverstein as Chief Financial Officer

SAN FRANCISCO, May 03, 2021 (GLOBE NEWSWIRE) — Excision BioTherapeutics (“Excision”), a leading developer of potentially curative CRISPR anti-viral therapies to improve patient lives, today announced the appointment of Christine Silverstein as Chief Financial Officer. Silverstein joins Excision with more than 15 years of financial leadership and capital markets expertise in the biopharmaceutical industry. “We […]

InterVenn Biosciences Announces That Arnold Levine Has Joined the Company’s Board of Advisors

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–InterVenn Biosciences today announced that Arnold Levine, Ph.D., has joined the Company’s Board of Advisors, effective March 19, 2021. Dr. Levine joins the InterVenn Board of Advisors as one of the pioneers of molecular cancer research. Dr. Levine and others discovered the p53 tumor suppressor protein, a molecule that inhibits tumor […]

6K Prepares for Major Advancement in Battery Materials with $25M Investment

NORTH ANDOVER, Mass., April 28, 2021 /PRNewswire/ — 6K, a rising star in the production of sustainable advanced materials for energy storage, today announced the creation of a Center of Excellence for its 6K Energy division focused on the development of sustainable battery materials for electric vehicles (EVs), grid storage and consumer goods. The company will […]

Ai-Media Acquires Market-Leading Video and Captioning Technology Company EEG

Ai-Media is delighted to announce today that we have agreed to acquire EEG enterprises. EEG is a market-leading North American video and captioning technology company. Its business focuses on innovative cloud workflow products for closed captioning, accessibility, and metadata processing applications. Ai-Media has worked closely with EEG for over five years and is a reseller […]

Ai-Media Launches Ground-Breaking Smart ASR™ Live Captions

Automatic Speech Recognition – also known as ASR – has been an area of rich development in the tech industry over the past several years. Many ASR systems have learned to produce automatic captions to a certain degree of accuracy, but many have been disappointing for consumers. But not all automatic captioning is equal. Today, […]

InterVenn Biosciences Announces Additions to the Company’s Executive Team

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–InterVenn Biosciences today announced additions to the Company’s executive team in the month of April. Stephana Patton, Ph.D., J.D. joins InterVenn as Chief Legal Officer (CLO). Dr. Patton brings over twenty years of legal experience to InterVenn. She was most recently General Counsel, Corporate Secretary, and Chief Compliance Officer at Eiger […]

InterVenn Biosciences Announces that Nobel Laureate James P. Allison, PhD, has Joined the Company’s Board of Advisors

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–InterVenn Biosciences today announced that Nobel Prize recipient, James P. Allison, has joined the company’s Board of Advisors, effective March 9, 2021. Dr. Allison joins the InterVenn Board of Advisors with over 45 years of experience in Immunology and cancer research. James Allison is the Regental Professor and Chair of the […]